NCT03194204 is a NA clinical trial of Doxycycline Tablets in Rheumatoid Arthritis, sponsored by Assiut University.

Who is sponsoring NCT03194204?

NCT03194204 is sponsored by Assiut University.

What drugs are being tested in NCT03194204?

Interventions in NCT03194204: Doxycycline Tablets.

What condition does NCT03194204 study?

NCT03194204 studies Rheumatoid Arthritis.

Is NCT03194204 still recruiting?

NCT03194204 is currently completed. Last updated 18 May 2020.

Last reviewed 2020-05-18 · How we verify

NCT03194204

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Re-evaluation of Some Old Rheumatoid Arthritis Therapy: A Randomized Controlled Trial

Completed NA Last updated 18 May 2020

What this trial tests

NA trial testing Doxycycline Tablets in Rheumatoid Arthritis in 160 participants. Completed in 20 February 2020.

Timeline

1 October 2019

Primary endpoint
20 February 2020

20 February 2020

Quick facts

Lead sponsor	Assiut University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	160
Start date	1 October 2019
Primary completion	20 February 2020
Estimated completion	20 February 2020
Sites	1 location across Egypt

Drugs / interventions tested

Doxycycline Tablets — full drug profile →

Conditions studied

Rheumatoid Arthritis — all drugs for Rheumatoid Arthritis →

Sponsor

Assiut University

Who can join

Adults 18 to 60, any sex, with Rheumatoid Arthritis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Rheumatoid Arthritis (RA) is a chronic inflammatory disease characterized by joint swelling, joint tenderness and destruction of synovial joints, leading to severe disability and premature mortality.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Immunotherapy of Autoimmune Diseases with Nonantibiotic Properties of Tetracyclines.
Park CS, Kim SH, Lee CK. · · 2020 · cited 25× · PMID 33425432 · DOI 10.4110/in.2020.20.e47
Predictors of Cardiovascular Affection in Patients with Active Rheumatoid Arthritis: Secondary Analysis of a Randomized Controlled Trial.
Ibrahem EM, El-Gendi SS, Mahmoud AA, Abdel-Aal SM, et al · · 2021 · cited 3× · PMID 33185166 · DOI 10.2174/1573397116666201113090145

Verify or expand the search:

Other trials of Doxycycline Tablets

Trials testing the same drug.

NCT04729140 — An Outpatient Clinical Trial Using Ivermectin and Doxycycline in COVID-19 Positive Patients at High Risk to Prevent COVI · Phase 4 · unknown
NCT04715295 — Safety and Efficacy of Doxycycline and Rivaroxaban in COVID-19 · Phase 4 · unknown

Other recruiting trials for Rheumatoid Arthritis

Currently open trials in the same condition.

NCT07433335 — A Study to Assess the Safety and Tolerability of SR-878 in Patients With Rheumatoid Arthritis · Phase 1 · recruiting
NCT07491016 — Efficacy and Safety of Telitacicept Combined With Baricitinib for Refractory Rheumatoid Arthritis · recruiting
NCT07171983 — A Study to Evaluate the Safety, Tolerability, and Drug Levels of BMS-986454 in Participants With Rheumatoid Arthritis · Phase 1 · recruiting
NCT07246096 — Exploratory Clinical Study on the Safety and Efficacy of Anti- CD19/BCMA U CAR-T Cell Injection for the Treatment of Rel · EARLY_PHASE1 · recruiting
NCT07363590 — A Clinical Study of MK-1045 in People With Lupus or Rheumatoid Arthritis (MK-1045-004) · Phase 1 · recruiting

Other Assiut University trials

Trials by the same sponsor.

NCT07423312 — Lead Exposure and Multiple Sclerosis · not yet recruiting
NCT07234526 — Usage of Glucose Fluctuations as a Prognostic Marker in Septic Shock Patients · not yet recruiting
NCT07273214 — Knowledge, Attitude and Practice of Third Trimester Pregnant Mothers Towards Self-Medication in Assiut, Egypt · not yet recruiting
NCT07194863 — Efficacy of Essential Phospholipid Versus Betaine HCL/L-Glutamic Acid in MAFLD · not yet recruiting
NCT07053709 — Screening for Hyperuricemia in Patients With Metabolic Associated Fatty Liver Disease (MAFLD) · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03194204 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Assiut University
Last refreshed: 18 May 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03194204.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing